ETIDIOH - NEW: pandemic influenza

Showing posts with label pandemic influenza. Show all posts

Sunday, July 5, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, July 5 '26)

Ann Intern Med

Summary for Patients: Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone.
Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-26-00217.
PubMed

XIE Y, Choi T, Al-Aly Z
Adverse Events After Same-Day COVID-19 and Influenza Vaccination Versus Influenza Vaccination Alone : A Target Trial Emulation.
Ann Intern Med. 2026 Jun 30. doi: 10.7326/ANNALS-26-00217.
PubMed Abstract available

Antiviral Res

YANG X, Wu L, Wan G, Chen R, et al
The anti-respiratory syncytial virus activity of biochemicals from Pyrola incarnata.
Antiviral Res. 2026;252:106473.
PubMed Abstract available

Arch Virol

ALVES MCS, Falcao RM, de Jesus Palmeira OF, de Sa Leitao Paiva-Junior S, et al
Genomic and epidemiological characterization of SARS-CoV-2 in Northeastern Brazil: a comprehensive analysis (2020-2024).
Arch Virol. 2025;171:1.
PubMed Abstract available

NEHUL S, Nagaraj SK, Narayan R, Singh A, et al
A novel molecule inhibits SARS-CoV-2 RBD binding to the ACE2 receptor, blocks viral entry and exhibits antiviral activity in a murine model.
Arch Virol. 2026;171:98.
PubMed Abstract available

MOYUE X, Liang S, Ying X, Yang Y, et al
Research progress of nucleocapsid protein of novel coronavirus: structure, function and targeted therapy.
Arch Virol. 2026;171:120.
PubMed Abstract available

CHEPURNOV A, Miroshnichenko S, Ivanov M, Solomatina M, et al
Specific features of the infection caused by SARS-CoV-2 variants in Vero cell culture.
Arch Virol. 2026;171:133.
PubMed Abstract available

JONES LR, D'Andrea JS, Levite J, Brito M, et al
Viral genotype and the pace of epidemic waves: an assessment from SARS-CoV 2 genomics and wastewater surveillance data.
Arch Virol. 2026;171:163.
PubMed Abstract available

BMC Pediatr

ASAFO-AGYEI SB, Ameyaw E, Nguah SB, Paintsil V, et al
Immunisation status and clinical outcomes in children admitted to a Paediatric emergency unit in Ghana: a prospective cohort study.
BMC Pediatr. 2025;25:981.
PubMed Abstract available

PU F, Hao YQ
Impact of COVID-19 epidemic prevention and control measures on the incidence of asthma in children.
BMC Pediatr. 2026;26:8.
PubMed Abstract available

AVSAR H, Bulbul A, Bas EK, Uslu HS, et al
Maternal-infant vitamin D coupling and neonatal hypocalcemia: a six-year cohort integrating preterm risk, onset timing, and pandemic effects.
BMC Pediatr. 2026 Jan 27. doi: 10.1186/s12887-026-06532.
PubMed

MOHAMMADI R, Barzegar H, Zamani Z, Gorji M, et al
Hospitalization outcomes and laboratory correlations in pediatric MIS-C patients: a retrospective cross-sectional study in Tehran, Iran.
BMC Pediatr. 2026;26:205.
PubMed Abstract available

MIYAGI Y, Morimoto Y, Satake E, Iwashima S, et al
Identification of key clinical features for pediatric respiratory syncytial virus infection using machine learning.
BMC Pediatr. 2026;26:266.
PubMed Abstract available

COBAN Y, Evren G, Yildizdas D, Zengin N, et al
Burden, risk factors, and outcomes respiratory syncytial virus (RSV) infection in pediatric intensive care units in Turkiye (RSVP Study 2020-2024).
BMC Pediatr. 2026 Mar 5. doi: 10.1186/s12887-026-06562.
PubMed

AKALIN H, Kilic A, Ozcetin M, Yildiz I, et al
The effect of Covid 19 pandemic on childhood obesity in Turkey.
BMC Pediatr. 2026;26:310.
PubMed Abstract available

SCHMIDT L, Feddern S, Kossow A, Niessen J, et al
Severe acute COVID-19 and early long COVID signals in paediatric cohorts: an analysis of real-world data from two health departments, Germany.
BMC Pediatr. 2026;26:280.
PubMed Abstract available

HANSEN G, Holt T
RSV bronchiolitis versus COVID-19: could pediatric intensive care units have done more during the pandemic?
BMC Pediatr. 2026 Apr 11. doi: 10.1186/s12887-026-06850.
PubMed

J Gen Virol

KUOK DIT, Ma APY, Ching RHH, Ng KC, et al
Assessment of influenza virus and coronavirus tropism, replication competence and disease severity in ex vivo and in vitro cultures of the human respiratory tract.
J Gen Virol. 2026;107:002281.
PubMed Abstract available

J Virol

LI P, Zheng Y-M, Liu S-L
Altered infectivity, cell-cell fusion, and immune evasion of SARS-CoV-2 BA.3.2 and LP.8.1 variants.
J Virol. 2026 May 12:e0001626. doi: 10.1128/jvi.00016.
PubMed Abstract available

MCCABE M, Groves HE, Getty E, Campbell E, et al
Age-dependent expression and antiviral activity of interferon epsilon in respiratory epithelium.
J Virol. 2026 May 12:e0057825. doi: 10.1128/jvi.00578.
PubMed Abstract available

SIVARAJAN R, Kirchgatterer PC, Lawrenz J, Tanner-Matiz E, et al
Tonic and early interferons defend against respiratory viruses in primary human lung organoid-derived air-liquid interface cultures.
J Virol. 2026 May 20:e0210425. doi: 10.1128/jvi.02104.
PubMed Abstract available

FAN L, Gao X, Feng W, Huang Q, et al
SARS-CoV-2 ORF3a suppresses host antiviral interferon responses by promoting STUB1-mediated PTEN proteasomal degradation.
J Virol. 2026 Jun 2:e0018626. doi: 10.1128/jvi.00186.
PubMed Abstract available

SUSMA B, Spronken M, van Nieuwkoop S, Kalverda B, et al
Increased or decreased numbers of CpG dinucleotide motifs in the genome of influenza A virus do not affect in vitro virus phenotype.
J Virol. 2026 Jun 22:e0004726. doi: 10.1128/jvi.00047.
PubMed Abstract available

ZHANG Q, Zhang Y, Sun H, Li H, et al
Single-cell and spatial transcriptomic profiling reveals distinct immune landscapes in murine lungs infected with H1N1 versus H5N1 influenza viruses.
J Virol. 2026 Jun 29:e0074626. doi: 10.1128/jvi.00746.
PubMed Abstract available

KATO K, Okamura K, Nakamura Y, Iwata M, et al
Influenza A virus infection induces initial proliferation of commensal Streptococcus pneumoniae in the larynx leading to dissemination into the lower respiratory tract.
J Virol. 2026 Jun 29:e0055526. doi: 10.1128/jvi.00555.
PubMed Abstract available

Pediatrics

GERHART J, Leister-Tebbe H, Chan PLS, McComsey GA, et al
Nirmatrelvir/Ritonavir for the Treatment of COVID-19 in Children Aged 6 Years and Older.
Pediatrics. 2026 Jun 25:e2025073999. doi: 10.1542/peds.2025-073999.
PubMed Abstract available

ZMUDA E, Hannon TS, Valentic J
The Role of the Pediatrician to Promote Effective Approaches for Child and Adolescent Nutrition in Schools: Policy Statement.
Pediatrics. 2026 Jun 15:e2026077404. doi: 10.1542/peds.2026-077404.
PubMed Abstract available

MEHROTRA-VARMA S, Nguyen HQ, Henry S, Collins J, et al
Long-Term Outcomes of Multisystem Inflammatory Syndrome in Children up to 4.5 Years After COVID-19.
Pediatrics. 2026;158:e2025075578.
PubMed Abstract available

PLoS One

HUANG L, Wang TM, Sugimoto JD, Heberer KR, et al
Association of SARS-CoV-2 infection with incident diabetes among U.S. Veterans in a prospective longitudinal cohort.
PLoS One. 2026;21:e0351992.
PubMed Abstract available

ALLARDET-SERVENT J, Hezard N, Pissier C, Bardin N, et al
Circulating biomarkers of bronchoalveolar injury help predict the need for mechanical ventilation in patients with moderate to severe COVID-19 pneumonia: A prospective cohort study.
PLoS One. 2026;21:e0337792.
PubMed Abstract available

NAZIR A, Shorfuzzaman M, Lotfi ML, Kamalov F, et al
Forecasting COVID-19 new cases using NBEATS deep learning and mobility data.
PLoS One. 2026;21:e0350264.
PubMed Abstract available

WERTZ E, Babinska M, Batorski D, Louison-Lavoy D, et al
Ad-based social media interventions increase belief accuracy and generate pro-social opinions among non-news readers.
PLoS One. 2026;21:e0352588.
PubMed Abstract available

HERNANDEZ-ORTIZ BA, Dos Santos TA, Appolinario CM, Arcila-Cardona AM, et al
Spatial association of seabirds and aquatic birds with highly pathogenic avian influenza (H5N1) outbreaks in Brazil: A nationwide ecological and statistical modelling approach.
PLoS One. 2026;21:e0350505.
PubMed Abstract available

KEARNEY GD, Obi ON, Maddipati V, Levitin G, et al
Social vulnerability and spatial patterns of COVID-19 mortality: Global implications for respiratory health equity.
PLoS One. 2026;21:e0352270.
PubMed Abstract available

KATUSIIME L, Agbola FW
Determinants of mobile money loan disbursements: Evidence from Uganda's post pandemic digital credit boom.
PLoS One. 2026;21:e0338535.
PubMed Abstract available

KIERNAN EA, Guzman JD
Paying in public: Peer effects, impression management, and willingness to pay on digital payment platforms.
PLoS One. 2026;21:e0340550.
PubMed Abstract available

Proc Natl Acad Sci U S A

CAO J, Liu S, Su C, Wang L, et al
Genomic and structural evidence of SARS-CoV-2 and MERS-CoV in migratory birds.
Proc Natl Acad Sci U S A. 2026;123:e2400023123.
PubMed Abstract available

METZGER SM, Jones TC, Meier JIJ, Richter A, et al
Evaluation of a proposed link between the SARS-CoV-2 furin cleavage site and mouse-adapted MERS-coronavirus MA30.
Proc Natl Acad Sci U S A. 2026;123:e2601806123.
PubMed Abstract available

TYLLIS TS, Norton TS, Abbott C, McPeake DJ, et al
B cell-intrinsic CXCR3 drives efficient generation of ectopic pulmonary germinal center responses to influenza A virus infection.
Proc Natl Acad Sci U S A. 2026;123:e2535787123.
PubMed Abstract available

SOEWONGSONO AC, Thompson A, Landis MJ
Inferring epidemiological parameters under an infectious phylogeography model with visitor dynamics.
Proc Natl Acad Sci U S A. 2026;123:e2535042123.
PubMed Abstract available

Vaccine

YADEGARYNIA D, Keyvanfar A, Keyvani H, Tehrani S, et al
Corrigendum to "Immunogenicity and safety of a quadrivalent recombinant influenza vaccine manufactured in Iran (FluGuard) in volunteers aged 18-60 years: A double-blind, non-inferiority, randomized controlled trial" [Vaccine 42(9) (2024) 2254-2259].
Vaccine. 2026;88:128881.
PubMed

BARBAROUX A, Serati I, Milhabet I
Effectiveness and acceptability of an opt-out nudge to promote influenza vaccination among medical residents: A randomized controlled trial.
Vaccine. 2026;89:128894.
PubMed Abstract available

MORRIS SE, O'Halloran A, Sundaresan D, Olson SM, et al
Public health benefits of maternal influenza vaccination among pregnant women and infants <6 months in the United States, 2011-2020.
Vaccine. 2026;89:128895.
PubMed Abstract available

HALWE NJ, Krammer F
Vaccine strategies and development before and during the 1968 H3N2 influenza pandemic.
Vaccine. 2026;89:128877.
PubMed Abstract available

Giuseppe Michieli

I am an Italian blogger, active since 2005 with main focus on emerging infectious diseases such as avian influenza, SARS, antibiotics resistance, and many other global Health issues. Other fields of interest are: climate change, global warming, geological and biological sciences. My activity consists mainly in collection and analysis of news, public services updates, confronting sources and making decision about what are the 'signals' of an impending crisis (an outbreak, for example). When a signal is detected, I follow traces during the entire course of an event. I started in 2005 my blog ''A TIME'S MEMORY'', now with more than 40,000 posts and 3 millions of web interactions. Subsequently I added an Italian Language blog, then discontinued because of very low traffic and interest. I contributed for seven years to a public forum (FluTrackers.com) in the midst of the Ebola epidemic in West Africa in 2014, I left the site to continue alone my data tracking job.

Friday, July 3, 2026

#Vaccine #strategies and #development before and during the 1968 #H3N2 #influenza #pandemic

Abstract

Nearly 60 years ago, in 1968, the global population was confronted with the emerging pandemic influenza A virus (IAV) subtype H3N2 (1968 H3N2pdm). An estimate of up to two million fatalities have been linked to 1968 H3N2pdm, and the H3N2 subtype continues to circulate as seasonal IAV among humans until today. The last IAV pandemic dates back to the year 2009 but concerns about a new IAV pandemic in the near future are increasing. The global spread of H5N1 highly pathogenic avian influenza virus and its spill-over into new mammalian hosts, discovery of novel influenza A virus with zoonotic or even pandemic potential, as well as seasonal influenza viruses undergoing antigenic changes necessitate constant vigilance. Here, we highlight the proactive actions, precautionary measures and vaccination strategies used during the 1968 H3N2 IAV pandemic. Our review highlights the emergence and spread of 1968 H3N2pdm over the course of the pandemic, alongside a delineation of vaccine development before, during and after the 1968 pandemic. Updating these strategies in the context of new findings combined with our experiences during the coronavirus disease 2019 (COVID-19) pandemic is necessary to improve preparedness for the next pandemic. Influenza viruses with zoonotic potential will remain a constant threat to public health, and improving countermeasures and communication to the public is key to limit the pandemic ramifications.

Source:

Link: https://www.sciencedirect.com/science/article/abs/pii/S0264410X26006869?via%3Dihub

____

Giuseppe Michieli

Saturday, June 27, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 27 '26)

BMC Pediatr

LU Q, Yu D, Liang Y, Meng Q, et al
Antimicrobial resistance of Group A Streptococcus isolates from patients in Shenzhen, China during COVID-19 pandemic.
BMC Pediatr. 2026 Jan 9. doi: 10.1186/s12887-025-06448.
PubMed

DOKHAN-VURAL S, Kahlert CR, Roduit C, Heldt K, et al
Health-related quality of life, glycaemic control, lifestyle characteristics and SARS-CoV-2 prevalence in children with type 1 diabetes during the COVID-19 pandemic: results of a longitudinal, prospective single-centre Swiss study.
BMC Pediatr. 2026 Jan 6. doi: 10.1186/s12887-025-06375.
PubMed Abstract available

TIAN L, Hu X, Qin Y, Li L, et al
Early prediction of severe RSV-associated ALRTI in Asian pediatric patients: a simple nomogram.
BMC Pediatr. 2025;25:968.
PubMed Abstract available

IBRAHIM HM, Kotby A, El-Ghoneimy DH, El Gendy YG, et al
"Characteristics of children with multisystem inflammatory syndrome in children during different COVID-19 waves "Single centre Study".
BMC Pediatr. 2025;25:988.
PubMed Abstract available

YANG M, Wang Y, Gao J, Yao C, et al
Impact of SARS-CoV-2 variants and vaccination on pediatric febrile seizures: a retrospective cohort study.
BMC Pediatr. 2025;25:929.
PubMed

Cell

WACHARAPLUESADEE S, Saikruang W, Lytras S, Matsumoto K, et al
Virological characteristics of SARS-CoV-2-related coronaviruses dynamically circulating in Southeast Asia.
Cell. 2026;189:4075-4093.
PubMed Abstract available

Drugs

KANG C
Pixavir Marboxil: First Approval.
Drugs. 2026;86:1141-1145.
PubMed Abstract available

J Virol Methods

IKRAR T, Muchsin W, Sophian A
Beyond strain-specific immunity: Conserved antigenic targets, emerging platforms, and translational challenges in universal influenza and pan-coronavirus vaccine development.
J Virol Methods. 2026;345:115432.
PubMed Abstract available

Pediatrics

ARCHER HI, Watson A, Liao LD, Jacobson KB, et al
Concordance Between Maternal and Infant COVID-19 and Influenza Vaccination Status.
Pediatrics. 2026 Jun 24:e2025075163. doi: 10.1542/peds.2025-075163.
PubMed Abstract available

PLoS Comput Biol

DONG W, Yang Q, Xu L, Li X, et al
TCRBinder: Unified pre-trained language model with paired-chain synergy for predicting T-cell receptor binding specificity.
PLoS Comput Biol. 2026;22:e1014396.
PubMed Abstract available

PLoS Med

GHISI GLM, Carson RP, Turk Adawi K, Ding R, et al
Comparisons of core component delivery in cardiac rehabilitation programs by country income classification and decade based on the 2025 Global Audit Update: A survey study.
PLoS Med. 2026;23:e1005151.
PubMed Abstract available

PLoS One

ISHIGAKI Y, Fujita N, Kato T, Ochiai T, et al
Airborne spread of severe acute respiratory syndrome coronavirus 2 between rooms in a sealed, mechanically ventilated ward: Evidence from a hospital outbreak investigation.
PLoS One. 2026;21:e0350608.
PubMed Abstract available

MARTINS A, Bosco Santos MF, Nascimento J, da Silva Chui FM, et al
Effectiveness of CoronaVac in a pioneer risk-based allocation clinical trial during the COVID-19 pandemic.
PLoS One. 2026;21:e0351566.
PubMed Abstract available

CHEN YH, Lin CH, Liu JH, Lin HA, et al
Effects of incentive spirometer training on dyspnea and functional status in patients with long COVID.
PLoS One. 2026;21:e0351553.
PubMed Abstract available

BETTIO F, Tavares FF, Ticci E
Intimate partner violence during lockdown in Tuscany, Italy: Economic or confinement-related shocks?
PLoS One. 2026;21:e0349889.
PubMed Abstract available

CHEN X, Gao J, Qin Q, Wang C, et al
Will there be new trends in the public's attention to express services in the post-COVID-19 era?
PLoS One. 2026;21:e0348096.
PubMed Abstract available

CHASCIAR V, Chasciar DR, Coman C, Gherhes V, et al
Workplace changes, perceived difficulties and migration intentions among Romanian construction workers during the covid-19 pandemic.
PLoS One. 2026;21:e0335155.
PubMed Abstract available

KEITA NY, Onywera H, Abdou M, Dicko Z, et al
A tale of SARS-CoV-2 genomic surveillance in Mali: Variants introductions and transmission dynamics.
PLoS One. 2026;21:e0352020.
PubMed Abstract available

RAVINDRARAJAH R, Gittins M, Paterson L, Rogers G, et al
Clinical and cost-effectiveness of the digital intervention, MyWay Diabetes, in people with type 2 diabetes living in Greater Manchester during the COVID-19 pandemic.
PLoS One. 2026;21:e0349232.
PubMed Abstract available

MAJEWSKA M, Mazdziarz MA, Lepiarczyk E, Lipka A, et al
Severity-dependent metabolic rewiring in COVID-19 based on untargeted metabolomic profiling of patient plasma.
PLoS One. 2026;21:e0352437.
PubMed Abstract available

YU J, Bekerian DA, Khandelwal R
Why do people comply with health guidelines in a competing information environment?
PLoS One. 2026;21:e0352421.
PubMed Abstract available

YUMIYA Y, Itakura M, Shiroma N, Murayama H, et al
Factors associated with the duration of telephone observation and consultation sessions provided by the Hiroshima Prefecture Follow-up Center in the later stages of the COVID-19 pandemic in Japan.
PLoS One. 2026;21:e0352251.
PubMed Abstract available

WILLIAMS SL, Beadle E, Williams P, Master H, et al
A mixed-methods analysis of the implementation of a new community long-COVID service during the 2020 pandemic: Learning from practice.
PLoS One. 2026;21:e0313367.
PubMed Abstract available

FARIS N, Hamdar L, Tamim H, Makki M, et al
Emergency department visits and disease patterns during and after the COVID-19 lockdown.
PLoS One. 2026;21:e0352275.
PubMed Abstract available

CHANG YS, Jones J, Hong SA, Chien LY, et al
Factors associated with multiple births in the United Kingdom during COVID-19: A cross-sectional survey.
PLoS One. 2026;21:e0352340.
PubMed Abstract available

BIACKOVA N, Laskov O, Adamova A, Piorecka V, et al
Transcranial direct current stimulation in affecting neuropsychiatric symptoms of post-COVID syndrome: No change in microstates and functional connectivity.
PLoS One. 2026;21:e0351407.
PubMed Abstract available

LAMB D, Scott H, Carr E, Stevelink SAM, et al
Mental health of healthcare workers in England during the first three years of the COVID-19 pandemic: The NHS CHECK study cohort.
PLoS One. 2026;21:e0350918.
PubMed Abstract available

Proc Natl Acad Sci U S A

KIM T, Biswas A, Kandel S, Kuroda M, et al
Extra gene coding capacity of SARS-CoV-2 provides a virus engineering platform for in vitro and in vivo applications.
Proc Natl Acad Sci U S A. 2026;123:e2532920123.
PubMed Abstract available

Vaccine

MAGNUSSON AC, Lim S, Niemi C, Wolf N, et al
Intranasal influenza vaccination using an outer membrane vesicle platform.
Vaccine. 2026;89:128876.
PubMed Abstract available

CHEN S, Fang Y, Yu FY, Ding L, et al
Systematic review and meta-analysis of digital seasonal influenza vaccination promotion in people aged >/=50 ?years.
Vaccine. 2026;88:128865.
PubMed Abstract available

LEVATI E, Calvani R, Cacciatore S, Tosato M, et al
Influenza, pneumococcal, and herpes zoster vaccination in Italy: Knowledge, uptake, and determinants across the adult life course.
Vaccine. 2026;88:128853.
PubMed Abstract available

COUTO MONIZ M, Luo S, Krokhin A, Egorov A, et al
Purified gamma-irradiated influenza A vaccine demonstrates high immunogenicity and protection against a drifted H1N1 strain.
Vaccine. 2026;88:128872.
PubMed Abstract available

SHINJOH M, Furuichi M, Sugimoto R, Kawakami C, et al
Effectiveness of inactivated and live-attenuated influenza vaccines in children during the 2025-2026 influenza season with genetically distinct influenza A and B viruses.
Vaccine. 2026;88:128869.
PubMed Abstract available

Virology

CHOWDHURY D, Vanderven HA, Wangchuk P, Sarker S, et al
Mechanistic insights into flavonoid-mediated regulation of human influenza virus replication.
Virology. 2026;623:111012.
PubMed Abstract available

HEREMIA L, Langsbury H, Treece J, Miller AK, et al
Rapid GeneXpert surveillance of influenza A virus in seabirds and the environment provides early warning for wildlife health in Aotearoa New Zealand.
Virology. 2026;623:111014.
PubMed Abstract available

Giuseppe Michieli

Saturday, June 20, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Jun. 20 '26)

Ann Intern Med

KOUTOURATSAS T, Dammad T, Mylonakis E
In outpatients with COVID-19 during Omicron variant circulation, some antivirals reduce time to recovery.
Ann Intern Med. 2026 Jun 2. doi: 10.7326/ANNALS-26-01878.
PubMed Abstract available

COTTON D
"Never More Than 15 Feet From the Respirator": Housestaff Research During the 1955 Boston Polio Epidemic.
Ann Intern Med. 2026 Apr 28. doi: 10.7326/ANNALS-25-05440.
PubMed Abstract available

Arch Virol

AHMADY A, Mickleburgh I, Bryant N, Carnell GW, et al
Enhanced virucidal activity of quaternary ammonium compound-thymol combinations: influence of mucin and mucoadhesive polymers.
Arch Virol. 2026;171:215.
PubMed Abstract available

SANYAL D, Chaubey B
SARS-CoV-2 3CL protease interaction with host factors - identifying novel drug targets.
Arch Virol. 2026;171:202.
PubMed Abstract available

BMC Pediatr

GRUENDL M, Campos LN, Dey T, Nkurunziza T, et al
Epidemiology of children and adolescents undergoing surgery at Mexican public hospitals: a retrospective registry-based analysis from 2010 to 2022.
BMC Pediatr. 2026;26:553.
PubMed Abstract available

KARADENIZ HB, Zilan S, Yazici MB, Derelioglu SS, et al
COVID-19 and first permanent molar extractions in children: a comparative retrospective study.
BMC Pediatr. 2026;26:567.
PubMed Abstract available

Cell

UEKI H, Tomita Y, Duong C, Mitake H, et al
A CRISPR knockout mouse library for functional genomics in influenza research.
Cell. 2026 Jun 16:S0092-8674(26)00591-X. doi: 10.1016/j.cell.2026.
PubMed Abstract available

Epidemiol Infect

NEMCOVA B, Goldstein IH, Sebastian J, Minin VM, et al
Unjustified Poisson assumptions lead to overconfident estimates of the effective reproductive number.
Epidemiol Infect. 2026;154:e79.
PubMed Abstract available

J Epidemiol Community Health

MOSCROP A, Dorling D, Cole T
'British children are not shrinking', but child height is increasing for the wrong reasons: trends and inequalities in child measurement programme data for England, Scotland and Wales.
J Epidemiol Community Health. 2026;80:534-540.
PubMed Abstract available

J Gen Virol

NABIL NM, Tawakol MM, Hagag N, Eid S, et al
Molecular surveillance and predictive risk modelling of avian influenza virus in wild birds in Egypt.
J Gen Virol. 2026;107:002278.
PubMed Abstract available

J Infect

LU L, Long Z, Chen F, Li Z, et al
Global Disability-Adjusted Life Years Burden of Lower Respiratory Infections Caused by Streptococcus pneumoniae, Staphylococcus aureus, and Klebsiella pneumoniae, 1990-2021: A Systematic Analysis of the Global Burden of Disease Study 2021.
J Infect. 2026 May 25:106768. doi: 10.1016/j.jinf.2026.106768.
PubMed Abstract available

J Infect Dis

NURMI V, Hedman L, Vapalahti K, Hepojoki J, et al
Anti-spike IgG Avidity Enhances Neutralization of Severe Acute Respiratory Syndrome Coronavirus 2: A Prospective Study of Primary Infections and Immunizations.
J Infect Dis. 2026;233:e1374-e1385.
PubMed Abstract available

CASERTA MT, Mariani TJ, Walsh EE, Gill SR, et al
Nasal Biomarkers of Acute Illness Severity and Predictors of Recurrent Wheeze in Infants Infected With Respiratory Syncytial Virus.
J Infect Dis. 2026;233:1027-1035.
PubMed Abstract available

LIN DY, Mischell MA, Zhang X, Mollan KR, et al
Incidence and Severity of Postacute Sequelae of SARS-CoV-2 Infection in the Omicron Era: A Prospective Cohort Study.
J Infect Dis. 2026;233:1063-1068.
PubMed Abstract available

J Virol

LV C, Wang S, Song M, Wu J, et al
The nicotinamide phosphoribosyltransferase inhibitor FK866 restricts influenza A virus replication by perturbing viral polymerase activity.
J Virol. 2026 Jun 15:e0059126. doi: 10.1128/jvi.00591.
PubMed Abstract available

NGUYEN X-D, Le BT, Bleich J, Espada C, et al
Environmental temperature and relative humidity shape post-emission aerosol fate and airborne influenza transmission.
J Virol. 2026 Jun 15:e0063426. doi: 10.1128/jvi.00634.
PubMed Abstract available

HUI X, Tian X, Xue C, Ding S, et al
KCMF1-mediated influenza A virus PB1 ubiquitination at K653 regulates viral replication.
J Virol. 2026 Jun 15:e0048126. doi: 10.1128/jvi.00481.
PubMed Abstract available

Lancet

ABUBAKAR I, Tellez D, Aldridge RW, Altare C, et al
The UCL-Lancet Commission on Migration and Health: review of the state of progress.
Lancet. 2026;407:2554-2576.
PubMed Abstract available

PLoS Comput Biol

MCKINLEY TJ, Williamson DB, Xiong X, Salter JM, et al
On real-time calibrated prediction for complex model-based decision support in pandemics: Part 2.
PLoS Comput Biol. 2026;22:e1014299.
PubMed Abstract available

SHEFFIELD T, Bruneau RC, Won S, Sale KL, et al
Combining machine learning and iterative experiments to keep pace with emerging viral variants of concern.
PLoS Comput Biol. 2026;22:e1014394.
PubMed Abstract available

PLoS One

HIRABAYASHI K, Lorman V, Wuller S, Aragon LV, et al
Evaluation of steroids for acute COVID in the prevention of long COVID in children: An EHR and pediatric cohort study from the RECOVER Initiative.
PLoS One. 2026;21:e0350888.
PubMed Abstract available

ALENAZI S, Mohanty J, Srinivasan M, Samontaray DP, et al
"The impact of COVID-19 on employee productivity and the future of remote work".
PLoS One. 2026;21:e0351968.
PubMed Abstract available

HEUDORF U, Kowall B
All?cause excess mortality in Germany peaked during the late?2022 influenza period, exceeding peaks during SARS?CoV?2 waves (2020-2023).
PLoS One. 2026;21:e0335982.
PubMed Abstract available

KIM SJ, Kim J
Symptom profiles and health-related quality of life in Korean adults with post-acute sequelae of SARS-CoV-2 infection (PASC): A latent profile analysis.
PLoS One. 2026;21:e0351506.
PubMed Abstract available

HOLDSWORTH L, Jackson M, Piggin L, Kambulandu M, et al
The experiences of doctors in Lesotho during the COVID-19 pandemic: A qualitative study.
PLoS One. 2026;21:e0350935.
PubMed Abstract available

HELMSDAL G, Kristiansen MF, Gaard EK, Eysturoy BJ, et al
Persistent symptoms, cognitive impairment, and clinical predictors of long COVID one year after Omicron infection: A clinical case-control study from the Faroe Islands.
PLoS One. 2026;21:e0351564.
PubMed Abstract available

KEHL-FLOBERG K, Freisberg E, Pop-Vicas A, Gangnon R, et al
Long COVID risk by pre-infection symptoms and functional status: A retrospective cohort study of data from the All of Us Research Program.
PLoS One. 2026;21:e0330793.
PubMed Abstract available

BHAN PC, Schroeder M, Turchet D, Wen J, et al
The time sensitivity of aspirational interventions: Evidence from a role-modeling RCT.
PLoS One. 2026;21:e0350832.
PubMed Abstract available

WHITE DL, NonoDjotsa ABS, Ahmed ST, Boyle SH, et al
Association between deployment and Gulf War Illness and adverse COVID outcomes in a nationwide cohort of 1990-1991 Gulf Era war veterans in the VA's Million Veteran Program.
PLoS One. 2026;21:e0348594.
PubMed Abstract available

REID-WESTOBY C, Duku E, Gaskin A, Janus M, et al
Chronic absenteeism in Canadian kindergarten classes, pre- and post-COVID-19, and its association with concurrent developmental vulnerability.
PLoS One. 2026;21:e0345192.
PubMed Abstract available

YANG SD, Qi F, Colwill K, Gingras AC, et al
SARS-CoV-2 infection in female sex workers from Nairobi, Kenya early in the COVID-19 pandemic: Seroincidence and behavioural associations.
PLoS One. 2026;21:e0327692.
PubMed Abstract available

GEBRETEKLE GB, Lan M, Xi M, Ximenes R, et al
Evaluating respiratory syncytial virus immunization strategies for infants in Canada: A cost-utility analysis.
PLoS One. 2026;21:e0351183.
PubMed Abstract available

NISSLEY-TSIOPINIS J, Fleming PF, Chan W, Langberg JM, et al
Cluster-randomized trial of Homework, Organization, and Planning Skills program compared to treatment as usual/waitlist for youth ages 11-14: Study protocol for conceptual replication.
PLoS One. 2026;21:e0343894.
PubMed Abstract available

EL-ATFY ES, Gadallah AM, Alsahangiti AM, Balogun OS, et al
Laplace Transform-Based Nonparametric Test of Exponentiality against DMRL class with preservation under the Homogeneous Poisson Shock Model and applications in survival analysis and reliability.
PLoS One. 2026;21:e0349216.
PubMed Abstract available

FATIMA Z, Surette MD, Marttala S, Leto D, et al
Microbiome analysis of bronchoalveolar lavage (BAL) specimens from immunocompromised patients with pneumonia compared to those from healthy volunteers.
PLoS One. 2026;21:e0351562.
PubMed Abstract available

TRAIN A, Vemuri KK, Coderre-Ball A, Silva-Valencia J, et al
Prescription patterns of inhaler medications from 2017 to 2023: A retrospective study using Ontario administrative healthcare data.
PLoS One. 2026;21:e0348119.
PubMed Abstract available

VASUDEV C, Mishra S, Rathi A, Fledderjohann J, et al
Diverse coping strategies for food insecurity: A qualitative study of economically precarious households in India in the context of COVID-19.
PLoS One. 2026;21:e0350020.
PubMed Abstract available

KHAM-KJING N, Kawila R, Tariyo P, Puapun K, et al
Etiology of severe acute respiratory infections among adults in northern Thailand using multiplex PCR: A post-COVID-19 surveillance study (2023-2024).
PLoS One. 2026;21:e0350198.
PubMed Abstract available

GODBOLE N, Choi S, Shim K, Liu Y, et al
A study protocol for mixed-methods evaluation of the structure, design, and availability of medical student wellbeing programs.
PLoS One. 2026;21:e0351759.
PubMed Abstract available

ROHAN H, Bochner AF, Brown L, Ortiz EM, et al
COVID-19 alert level systems-Lessons learnt for future public health emergencies: A qualitative study.
PLoS One. 2026;21:e0351209.
PubMed Abstract available

Proc Natl Acad Sci U S A

LEVITT M, Marten B, Oren G, Ioannidis JPA, et al
Reclassification and weighting of multiple causes of death: US death certificates 2003-2023.
Proc Natl Acad Sci U S A. 2026;123:e2604493123.
PubMed Abstract available

Vaccine

MALHOTRA G, Bilguche A, Eades O, Loftus MJ, et al
Coverage and missed opportunities for routine vaccination in adult travellers: a single-centre observational study.
Vaccine. 2026;86:128735.
PubMed Abstract available

KATANA EB, Kiiza D, Odongpiny EAL, Simbwa BN, et al
Willingness to receive Ebola vaccines among pregnant and lactating women in Kampala, Uganda: insights from a post-outbreak cross-sectional study.
Vaccine. 2026;86:128737.
PubMed Abstract available

GIANNINI F, Hogan AB, Blyth CC, Glass K, et al
Modelling the impact of long-acting monoclonal antibody, maternal vaccine and hybrid programs of RSV immunisation in temperate Western Australia.
Vaccine. 2026;86:128731.
PubMed Abstract available

DVORKIN J, Pico M, Guinazu G, Crespi MS, et al
Residual burden of severe RSV disease in infants during the first season of maternal RSVpreF immunization in Argentina: A hospital-based, multicentre, retrospective cohort study.
Vaccine. 2026;87:128773.
PubMed Abstract available

QI X, Smolders C
From COVAX deliveries to vaccination uptake in LMICs: a monthly panel analysis.
Vaccine. 2026;86:128763.
PubMed Abstract available

EIDEN AL, Zheng Y, Wang D, Frew PM, et al
Changes in attitudes and beliefs about childhood vaccination among parents in the United States: A repeat cross-sectional survey before and after the COVID-19 pandemic.
Vaccine. 2026;87:128760.
PubMed Abstract available

DELLA CIOPPA G, Sahai N, Dodeur V, Dutton JL, et al
Safety, immunogenicity, and dose ranging of a bivalent respiratory syncytial virus and human metapneumovirus glycoprotein F-molecular clamp vaccine candidate in older adults: 1-month interim analysis of an ongoing randomised, observer-blind, placebo-
Vaccine. 2026;87:128772.
PubMed Abstract available

MOROS A, Deulofeu M, Ribo M, Bosch-Rue E, et al
Multiple monovalent COVID-19 PHH-1V vaccine adaptations elicit homologous and cross-neutralizing antibody responses in mice.
Vaccine. 2026;87:128781.
PubMed Abstract available

SPILA-ALEGIANI S, Massari M, Cutillo M, Menniti-Ippolito F, et al
Safety of influenza vaccine during the vaccination campaign 2021/2022 in Italy: a self-controlled case series study.
Vaccine. 2026;88:128806.
PubMed Abstract available

BUSH C, Desai S, Wang H, Hsu WC, et al
Incidence of outcomes relevant to vaccine safety monitoring in the general population, after influenza vaccination, and after respiratory infections: a descriptive analysis of four US claims databases, 2022-2023.
Vaccine. 2026;88:128821.
PubMed Abstract available

CHRISTOU-ERGOS M, Sabahelzain MM, Bolsewicz KT, Kaufman J, et al
Australian adults' views on influenza vaccination: Implications for communication and service quality from a qualitative study.
Vaccine. 2026;88:128846.
PubMed Abstract available

LE MH, Tran ND, Nguyen TTT, Phan TTN, et al
Willingness to pay for influenza vaccination among the elderly in Vietnam: A triple-bounded dichotomous choice analysis of economic and behavioral determinants.
Vaccine. 2026;88:128852.
PubMed Abstract available

Virus Res

VALENZUELA-FUENZALIDA JJ, Velarezco LM, Silva V, Delgado F, et al
Occurrence of Myocarditis in Patients Immunized with Different Types of COVID-19 Vaccines: A Systematic Review and Meta-Analysis.
Virus Res. 2026 May 20:199748. doi: 10.1016/j.virusres.2026.199748.
PubMed Abstract available

MANZOOR M, Banday MS, Para BA, Rani VI, et al
Mental health strain due to COVID-19: Psychological distress and somatic symptoms among health care workers and the general population in Kashmir, India.
Virus Res. 2026;369:199753.
PubMed Abstract available

TRAMONTOZZI C, Riccio A, La Frazia S, Svicher V, et al
Antiviral activity of the non-steroidal anti-inflammatory drug indomethacin against respiratory syncytial virus.
Virus Res. 2026;369:199743.
PubMed Abstract available

Giuseppe Michieli

Saturday, June 13, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 13 '26)

Arch Virol

SMATTI MK, Al-Khatib H, Suleman M, Nizar M, et al
Functional and structural characterization of the SARS-CoV-2 spike N481K mutation.
Arch Virol. 2026;171:198.
PubMed Abstract available

J Infect
HARRIS R, Thirard R, McBrien C, Middleditch A, et al
Immunogenicity and safety of co-administration of a recombinant shingles vaccine with an mRNA COVID-19 or adjuvanted influenza vaccine: a randomised controlled trial.
J Infect. 2026 Jun 4:106784. doi: 10.1016/j.jinf.2026.106784.
PubMed Abstract available
CORRAO G, Sguazzini E, Gori A, Monti E, et al
All-cause mortality within seven days of COVID-19 vaccination: A matched cohort and self-controlled case series study in Lombardy, Italy.
J Infect. 2026;93:106769.
PubMed Abstract available
GUINOVART LJ, Westrhenen SEMH, Schuurman R, Bruijning-Verhagen PCJL, et al
Symptomatology of SARS-CoV-2 versus seasonal coronavirus infection in healthy young children.
J Infect. 2026 May 20:106762. doi: 10.1016/j.jinf.2026.106762.
PubMed Abstract available

J Infect Dis
LIU F, Gross FL, Li Z, House SL, et al
Birth cohort effects in adults associated with influenza A(H1N1)pdm09 vaccine effectiveness.
J Infect Dis. 2026 Jun 8:jiag294. doi: 10.1093.
PubMed Abstract available

J Virol
LIU Z, Fan M, Zeng Y, Zheng Y, et al
Gga-miR-92-targeted TNFRSF1B inhibits the replication of influenza A virus by degrading TRAF3.
J Virol. 2026 Jun 12:e0067426. doi: 10.1128/jvi.00674.
PubMed Abstract available
XU S, Zhang Q, Xie X, Zhou M, et al
A neutralizing nanobody targeting a conserved lateral patch on HA1 confers protection against multiple H7 avian influenza viruses.
J Virol. 2026 Jun 11:e0056326. doi: 10.1128/jvi.00563.
PubMed Abstract available
PENG M, Liu L, Li X, Yu X, et al
Pre-pandemic contraction, phase-specific rate variation, and site-specific antigenic adaptation shape influenza A(H3N2) evolutionary dynamics in Hubei, China.
J Virol. 2026 Jun 10:e0055626. doi: 10.1128/jvi.00556.
PubMed Abstract available

PLoS Comput Biol
LIN Z, Gao Y, Sun W
Supervised deep learning with gene functional annotation for cell classification.
PLoS Comput Biol. 2026;22:e1014327.
PubMed Abstract available
KWON J, Li K, Warren JL, Pandya S, et al
Utilizing virus genomic surveillance to predict vaccine effectiveness.
PLoS Comput Biol. 2026;22:e1014329.
PubMed Abstract available

PLoS One
TAM VCW, Yeung NCY, Kwok AWL
Getting over the hurdles to save lives: Incorporating perceived barriers into theory of planned behaviour (TPB) model to predict stated intention among Hong Kong trained laymen.
PLoS One. 2026;21:e0350392.
PubMed Abstract available
KONDO K, Morita I, Sakuma S, Ohsawa I, et al
Changes in tobacco sales before, during, and after the COVID-19 pandemic in Japan: An interrupted time series analysis.
PLoS One. 2026;21:e0350820.
PubMed Abstract available
WOODGATE RL, Mary-Quigley L, Bell A, Bennett M, et al
Youth's mental health journeys through the COVID-19 pandemic using arts-based methods in virtual environments.
PLoS One. 2026;21:e0349860.
PubMed Abstract available
KARAMI B, Rezaeian S, Bagherinia M, Shakiba E, et al
Social support and health related quality of life among older people in covid-19 pandemic: The mediating role of resilience.
PLoS One. 2026;21:e0342982.
PubMed Abstract available
YANG RJ, Wang M, Lyu L, You JL, et al
Pathogen spectrum and epidemiology of respiratory tract infections in Quzhou, Eastern China, from November 2023 to July 2024: A post?COVID?19 surveillance study.
PLoS One. 2026;21:e0346441.
PubMed Abstract available
BOLSHOV O, Chumachenko D
Reinforcement learning for policymaking in epidemic control: A scoping review.
PLoS One. 2026;21:e0351176.
PubMed Abstract available
LIU C, Liu H, Wei Y, Ye J, et al
Modeling the effects of meteorological factors and media-driven public awareness on seasonal influenza outbreaks.
PLoS One. 2026;21:e0342962.
PubMed Abstract available
LIU F, Lai T, Xu W, Li G, et al
ViralMultiNet: A structure-aware multimodal framework for viral protein function prediction in wastewater surveillance.
PLoS One. 2026;21:e0349393.
PubMed Abstract available
MOUNCHID PM, Shukla S, Steinert JI
The interplay of economic shocks and cultural practices in child marriage: Comparative evidence from India and Zambia during the COVID-19 pandemic.
PLoS One. 2026;21:e0346851.
PubMed Abstract available

Proc Natl Acad Sci U S A
ZHU Z, Fragkias M, Suh JW, McCoshan E, et al
The Urban Pulse: Diagnosing the urbanization process as spiky, cyclical, and asynchronous.
Proc Natl Acad Sci U S A. 2026;123:e2537770123.
PubMed Abstract available
SKELLY AN, Fan C, Keeffe JR, Okten AB, et al
mRNA delivery of a class 1/4 SARS-CoV-2 neutralizing antibody protects against diverse sarbecoviruses in a lethal mouse challenge model.
Proc Natl Acad Sci U S A. 2026;123:e2536870123.
PubMed Abstract available

Vaccine
WU X, Tao Y, Sun Y, Chen J, et al
Cost-effectiveness of free influenza vaccination policy for Chinese older adults: a modeling analysis using real-world data.
Vaccine. 2026;88:128782.
PubMed Abstract available
BIETZ A, Sandow P, Hartmann C, Steffan L, et al
Real-time in-season monitoring of adult influenza vaccination coverage rates in Germany: results from a repeated cross-sectional online survey.
Vaccine. 2026;88:128765.
PubMed Abstract available
SONG L, He G, Cui Y, Tan R, et al
Optimized flagellin enhances systemic and mucosal immune responses induced by SARS-CoV-2 virus-like particle vaccines.
Vaccine. 2026;87:128767.
PubMed Abstract available
FAIJUE DD, Bouaddi O, Segui AO, Morias B, et al
Catch-up and life-course vaccination policies for adult and adolescent migrants in low-and-middle income countries: A policy analysis.
Vaccine. 2026;85:128645.
PubMed Abstract available
FORNS J, Pajouheshnia R, Aurelius T, Bouck Z, et al
Risk of thrombosis with thrombocytopaenia syndrome (TTS) after vaccination with AZD1222: a European VAC4EU post-authorisation safety study.
Vaccine. 2026;86:128723.
PubMed Abstract available
POWELL A, Suwalowska H, Sankoh O, Guo C, et al
Recent enough to matter: Perceived temporal proximity, anxiety, and COVID-19 vaccine intent.
Vaccine. 2026;85:128717.
PubMed Abstract available
DALEXIS RD, Beogo I, Kibret TC, Cenat JM, et al
Racial disparities in coverage and determinants of childhood diphtheria, tetanus, and pertussis (DTaP) vaccination in Canada: a post-COVID-19 pandemic analysis.
Vaccine. 2026;85:128679.
PubMed Abstract available
KOIRALA A, Prasad SA, Tjiam MC, Britton PN, et al
SARS-CoV-2 Ancestral and Omicron variant immunity in Australian children in 2023, a seroprevalence study.
Vaccine. 2026;85:128705.
PubMed Abstract available
XU Y, Nyberg F, Marking U, Gisslen M, et al
Rare adverse events after COVID-19 vaccination among Swedish older adults-evidence from a nationwide register-based study.
Vaccine. 2026;85:128724.
PubMed Abstract available
DANCHIN M, Rak A, Vasiliadis S, Wang B, et al
Maternal preferences for infant respiratory syncytial virus (RSV) preventives: an Australian discrete choice experiment.
Vaccine. 2026;85:128710.
PubMed Abstract available
KOHLI M, Maschio M, Lee A, Kissler S, et al
The cost-effectiveness of vaccination against COVID-19 in at-risk populations and older adults in the United Kingdom: Projections using a dynamic transmission model.
Vaccine. 2026;85:128687.
PubMed Abstract available
TRANG TPH, Bazelier MT, Klungel OH, Bots SH, et al
Quality and methodological heterogeneity of COVID-19 vaccine safety studies focusing on the myocarditis safety signal: A systematic review, meta-analysis and meta-regression.
Vaccine. 2026;85:128722.
PubMed Abstract available
WANG R, Zhao Y, Yang J, Luo R, et al
Systemic BCG administration induces transcription factor signature in CD4(+) T cells that cooperates with IL-12 signaling to drive antiviral Th1 differentiation.
Vaccine. 2026;85:128720.
PubMed Abstract available

Virology
KOVACS E, Rios Carrasco M, Guerreiro Cabana MF, de Vries RP, et al
H5N1 2.3.4.4b HA E190D and Q226H mutations, picked up as minority variants in a patient, result in an inability to bind sialic acid.
Virology. 2026;621:110949.
PubMed Abstract available

Virus Res
TJARNHAGE E, Vatsveen TK, Raki M, Nemazee D, et al
Repurposing ALK Inhibitors as Influenza and Corona Virus Antivirals Targeting Lymphocyte Tyrosine Kinase (LTK).
Virus Res. 2026 Jun 9:199759. doi: 10.1016/j.virusres.2026.199759.
PubMed Abstract available

Giuseppe Michieli

Wednesday, June 10, 2026

#Antigenic mapping of #H2 #influenza viruses recognized by #ferret and #human sera and predicting antigenically significant sites

ABSTRACT

Influenza viruses cause hundreds of thousands of infections globally every year. In the past century, seasonal influenza viruses have included H1N1, H2N2, and H3N2 strains. H2N2 influenza viruses circulated in the human population between 1957 and 1968. Previously, our group demonstrated a lack of H2N2 influenza virus immunity in individuals born after 1968, as well as the effectiveness of hemagglutinin (HA)-based vaccines for multiple influenza virus subtypes. In this study, H2 antigenic maps and radial graphs were generated using previously published data from H2 HA vaccinations of ferrets and seasonal influenza vaccinations of humans. The antigenic maps revealed a stark difference in the clustering of HA antigens between ferrets and humans, and the radial graphs showed that specific antigen recognition varies greatly among different influenza preimmune ferrets. These maps also revealed the significant impact that different pre-existing immunities have on antigenic recognition and clustering of antigens after vaccine boost. From these data, we predicted two possible antigenically significant sites containing various mutations that have not been previously reported, and showed that one of these sites is relevant using mouse antisera.

Source:

Link: https://journals.asm.org/doi/10.1128/msphere.00022-26

____

Giuseppe Michieli

Saturday, June 6, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 6 '26)

Arch Virol

PERDANA WY, Tsuneki-Tokunaga A, Rahmi KA, Hinay AA Jr, et al
In vitro efficacy of anti-influenza active compounds against clinical isolates with high growth capability.
Arch Virol. 2026;171:200.
PubMed Abstract available

Biochem Biophys Res Commun

SHAO S, Dong ZY, Kang ZY, Zhang H, et al
Dynamic regulation-based stabilizing mutations are highly effective for designing RSV pre-fusion F mRNA vaccines.
Biochem Biophys Res Commun. 2026;825:153958.
PubMed Abstract available

Epidemiol Infect

SANE J
Rebuilding trust in public health: Beyond polarization.
Epidemiol Infect. 2026;154:e71.
PubMed Abstract available

HASSELL K, Andrews N, Dabrera G, Kall M, et al
Acute COVID-19 mortality in England in the omicron era: a national-level matched cohort study.
Epidemiol Infect. 2026;154:e70.
PubMed Abstract available

J Infect Dis

PRASERT K, Praphasiri P, Ditsungnoen D, Naosri S, et al
Risk of hospitalization related to influenza A(H3N2) virus subclade K, Thailand, June-December 2025.
J Infect Dis. 2026 May 31:jiag283. doi: 10.1093.
PubMed Abstract available

J Neurosurg Pediatr

ANDERSON MG, Pindrik J, Michelow IC, Anuar A, et al
Pediatric sinogenic and otogenic intracranial infections requiring neurosurgical intervention: a North American multicenter study in the era of COVID-19.
J Neurosurg Pediatr. 2026;37:621-631.
PubMed Abstract available

J Virol

CEIRR Risk Assessment Pipeline executive reports on H5N1 highly pathogenic avian influenza 2.3.4.4b, swine H1 1B.2, and H9N2 low pathogenicity avian influenza B4.7.2.
J Virol. 2026 Jun 3:e0054526. doi: 10.1128/jvi.00545.
PubMed Abstract available

STEARNS K, Marcink T, Pawlack E, Sobolik EB, et al
Human parainfluenza virus 3 fusion protein cleavage: a key determinant of infection and spread.
J Virol. 2026 Jun 3:e0212625. doi: 10.1128/jvi.02126.
PubMed Abstract available

TURNER AH, Jaffrani SA, Kubinski HC, Ajayi DP, et al
Rab11B is required for binding and entry of recent H3N2, but not H1N1, influenza A isolates.
J Virol. 2026 Jun 2:e0211125. doi: 10.1128/jvi.02111.
PubMed Abstract available

Pediatrics

ROSTAD CA, Healy CM, Nayak JL, Parameswaran L, et al
Maternal RSV Vaccination, Infant Nirsevimab, or Both: Interim Analysis of a Randomized Trial.
Pediatrics. 2026 May 4:e2025075223. doi: 10.1542/peds.2025-075223.
PubMed Abstract available

PLoS One

EKWUNIFE O, Mangenah C, Ngwira L, Corbett E, et al
Economic barriers to diagnostic equity: A multi-country analysis of patient costs for rapid SARS-CoV-2 testing in sub-Saharan Africa.
PLoS One. 2026;21:e0350288.
PubMed Abstract available

HEMBERG M, Hansen AL, Storgaard J, Blay-Cadanet J, et al
MAVS is important for antiviral defense against influenza A virus in a human respiratory epithelium model.
PLoS One. 2026;21:e0350839.
PubMed Abstract available

Proc Natl Acad Sci U S A

RIKANI A, Di Domenico L, Sabbatini CE, Navarro V, et al
Resetting population mobility responses under repeated nonpharmaceutical interventions: Implications for hypothesized pandemic fatigue.
Proc Natl Acad Sci U S A. 2026;123:e2533284123.
PubMed Abstract available

PAPADAKI M, Pavlos E, Dubourdeau M, Bailif V, et al
Polyunsaturated fatty acid-derived lipid mediator patterns determine viral pneumonia severity and risk for critical COVID-19.
Proc Natl Acad Sci U S A. 2026;123:e2534726123.
PubMed Abstract available

GRUNDY JG, Pujols-Beltran M
Bilingualism predicts executive function resilience after COVID-19 in aging.
Proc Natl Acad Sci U S A. 2026;123:e2532470123.
PubMed Abstract available

Vaccine

DE FIGUEIREDO A, Paterson P, Lin L, Mounier-Jack S, et al
Changing socio-demographic determinants of seasonal influenza acceptance in England during the pandemic and a framework for predicting future acceptance.
Vaccine. 2026;85:128629.
PubMed Abstract available

DAS S, Tenaglia BM, Riley D, Speed S, et al
BECC-adjuvanted hemagglutinin influenza vaccine promotes enhanced immunogenicity and protective efficacy.
Vaccine. 2026;87:128774.
PubMed Abstract available

Virus Res

SEDAGHAT M, Najafi F, Khosravi Shademani F, Rezaeian S, et al
Seasonal influenza vaccine and frequency of adverse events in health workers receiving two doses of AstraZeneca vaccine: a retrospective cohort study.
Virus Res. 2026;369:199757.
PubMed Abstract available

Giuseppe Michieli

ETIDIOH - NEW

Sunday, July 5, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, July 5 '26)

Friday, July 3, 2026

#Vaccine #strategies and #development before and during the 1968 #H3N2 #influenza #pandemic

Saturday, June 27, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 27 '26)

Saturday, June 20, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, Jun. 20 '26)

Saturday, June 13, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 13 '26)

Wednesday, June 10, 2026

#Antigenic mapping of #H2 #influenza viruses recognized by #ferret and #human sera and predicting antigenically significant sites

Saturday, June 6, 2026

#Influenza and Other Respiratory Viruses Research #References (AMEDEO, June 6 '26)

My New Space

Most Popular Posts